• Ichrogene
    Ichrogene

    Genetic Analysis and Chronic Disease Prediction

    #Series A, #South Korea, #Healthcare

    We developed a solution that analyzes genetic information to predict chronic diseases and drug sensitivity, securing over 40,000 customers in Korea, Thailand, North America, and other countries. Our company led a genomic data construction and cohort analysis project at the Korea Disease Control and Prevention Agency.

    Founder
    Youngah Shin링크드인
    Founded
    2017
    Go to market
    B2B
    Funded by NAVER D2SF
    Seed, 2019
    Latest Funded
    Series A, 2021